GlassScriptPhysician profile
Allan Joseph
NPI 1407825094
$5,864.48
in general payments reported to CMS, 2019-2025
45 companies · $569 in 2025
The $569 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $410 · 2021: $1,331 · 2022: $991 · 2023: $858 · 2024: $637 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,878.49 |
| Education | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $998.57 | 2019-2024 | |
| Novo Nordisk INC | $565.72 | 2019-2025 | Wegovy, Saxenda |
| Astellas Pharma US INC | $514.18 | 2019-2023 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $408.36 | 2019-2023 | Injectafer |
| Exeltis, USA INC. | $304.14 | 2020-2025 | Slynd |
| Gynesonics, INC. | $266.72 | 2021 | |
| Pfizer INC. | $263.83 | 2022-2025 | |
| Hologic Sales and Service, LLC | $248.03 | 2019-2024 | Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $245.74 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $207.37 | 2021-2025 | |
| Channel Medsystems, INC. | $161.07 | 2022-2025 | |
| Millicent US INC | $158.21 | 2020-2025 | Intrarosa, Femlyv, Femring |
| Therapeuticsmd, INC. | $136.74 | 2019-2022 | |
| Biogen, INC. | $123.21 | 2024-2025 | Zurzuvae |
| Mimedx Group, INC. | $118.56 | 2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $107.20 | 2019 | |
| Myovant Sciences INC. | $95.75 | 2021-2022 | |
| Allergan, INC. | $77.61 | 2019-2020 | |
| Dysis Medical, INC. | $76.48 | 2022 | |
| Organon LLC | $67.40 | 2022-2025 | Nexplanon |
| Caldera Medical, INC | $66.40 | 2022 | |
| Agile Therapeutics, INC. | $64.10 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $59.93 | 2023 | |
| Lupin INC. | $59.05 | 2019-2021 | |
| Amgen INC. | $47.64 | 2019-2025 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $41.84 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $39.80 | 2019 | |
| Davol INC. | $36.59 | 2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $33.32 | 2020-2024 | Ethicon, Enseal X1 |
| Monaghan Medical Corporation | $31.73 | 2024 | Aerochamber |
| Evofem Biosciences, INC. | $24.53 | 2023 | Phexxi |
| Baxter Healthcare | $24.53 | 2024 | Perclot |
| Northgate Technologies, INC. | $23.02 | 2024 | Stimsite |
| Axonics, INC. | $22.73 | 2023 | Axonics |
| Mylan Pharmaceuticals INC. | $19.54 | 2021 | |
| Coloplast Corp | $17.34 | 2025 | |
| Medtronic, INC. | $16.21 | 2022 | |
| Virtus Pharmaceuticals LLC | $15.93 | 2021 | |
| Avanos Medical | $14.14 | 2021 | |
| Coopersurgical, INC. | $13.71 | 2020 | |
| Glaxosmithkline, LLC. | $13.43 | 2021 | |
| Intuitive Surgical, INC. | $12.33 | 2020 | |
| Avion Pharmaceuticals | $12.06 | 2019 | |
| Aspira Women'S Health INC | $9.69 | 2024 | Ova1 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.